These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 10919073)
1. Recent outcome in the field of distamycin-derived minor groove binders. Cozzi P Farmaco; 2000 Mar; 55(3):168-73. PubMed ID: 10919073 [TBL] [Abstract][Full Text] [Related]
2. A new class of cytotoxic DNA minor groove binders: alpha-halogenoacrylic derivatives of pyrrolecarbamoyl oligomers. Cozzi P Farmaco; 2001; 56(1-2):57-65. PubMed ID: 11347968 [TBL] [Abstract][Full Text] [Related]
3. The discovery of a new potential anticancer drug: a case history. Cozzi P Farmaco; 2003 Mar; 58(3):213-20. PubMed ID: 12620417 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxics derived from distamycin A and congeners. Cozzi P; Mongelli N Curr Pharm Des; 1998 Jun; 4(3):181-201. PubMed ID: 10197039 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners. Beria I; Baraldi PG; Cozzi P; Caldarelli M; Geroni C; Marchini S; Mongelli N; Romagnoli R J Med Chem; 2004 May; 47(10):2611-23. PubMed ID: 15115402 [TBL] [Abstract][Full Text] [Related]
6. Distamycin derivatives as potential anticancer agents. Cozzi P IDrugs; 2001 May; 4(5):573-81. PubMed ID: 16012903 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A. Baraldi PG; Romagnoli R; Beria I; Cozzi P; Geroni C; Mongelli N; Bianchi N; Mischiati C; Gambari R J Med Chem; 2000 Jul; 43(14):2675-84. PubMed ID: 10893305 [TBL] [Abstract][Full Text] [Related]
8. Distamycin A as stem of DNA minor groove alkylating agents. Baraldi PG; Nûnez Mdel C; Espinosa A; Romagnoli R Curr Top Med Chem; 2004; 4(2):231-9. PubMed ID: 14754456 [TBL] [Abstract][Full Text] [Related]
9. Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: synthesis and antitumour activity. Baraldi PG; Romagnoli R; Giovanna Pavani M; del Carmen Nunez M; Bingham JP; Hartley JA Bioorg Med Chem; 2002 May; 10(5):1611-8. PubMed ID: 11886822 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic halogenoacrylic derivatives of distamycin A. Cozzi P; Beria I; Caldarelli M; Capolongo L; Geroni C; Mongelli N Bioorg Med Chem Lett; 2000 Jun; 10(11):1269-72. PubMed ID: 10866397 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and preliminary cytotoxicity of nitrogen mustard derivatives of distamycin A. Wang Y; Wright SC; Larrick JW Bioorg Med Chem Lett; 2003 Feb; 13(3):459-61. PubMed ID: 12565950 [TBL] [Abstract][Full Text] [Related]
12. Development of distamycin-related DNA binding anticancer drugs. Marchini S; Broggini M; Sessa C; D'Incalci M Expert Opin Investig Drugs; 2001 Sep; 10(9):1703-14. PubMed ID: 11772279 [TBL] [Abstract][Full Text] [Related]
13. Alpha-bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity. Marchini S; Cirò M; Gallinari F; Geroni C; Cozzi P; D'Incalci M; Broggini M Br J Cancer; 1999 Jun; 80(7):991-7. PubMed ID: 10362106 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, DNA binding, cytotoxicity and sequence specificity of a series of imidazole-containing analogs of the benzoic acid mustard distamycin derivative tallimustine containing an alkylating group at the C-terminus. Brooks N; Lee M; Wright SR; Woo S; Centioni S; Hartley JA Anticancer Drug Des; 1997 Oct; 12(7):591-606. PubMed ID: 9365504 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders. Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic and antitumor activity of MEN 10710, a novel alkylating derivative of distamycin. Bigioni M; Salvatore C; Palma C; Manzini S; Animati F; Lombardi P; Pratesi G; Supino R; Zunino F Anticancer Drugs; 1997 Oct; 8(9):845-52. PubMed ID: 9402311 [TBL] [Abstract][Full Text] [Related]
17. The role of base excision repair in the repair of DNA adducts formed by a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size. Brooks N; McHugh PJ; Lee M; Hartley JA Anticancer Drug Des; 1999 Feb; 14(1):11-8. PubMed ID: 10363024 [TBL] [Abstract][Full Text] [Related]
18. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents. Coley HM; Mongelli N; D'Incalci M Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological activity of hybrid compounds between uramustine and DNA minor groove binder distamycin A. Baraldi PG; Romagnoli R; Guadix AE; Pineda de las Infantas MJ; Gallo MA; Espinosa A; Martinez A; Bingham JP; Hartley JA J Med Chem; 2002 Aug; 45(17):3630-8. PubMed ID: 12166936 [TBL] [Abstract][Full Text] [Related]
20. The alkylating antitumor drug tallimustine does not induce DNA repair. Rossi R; Montecucco A; Capolongo L; Mezzina M; Chevallier-Lagente O; Sarasin A; Ciarrocchi G Anticancer Res; 1996; 16(6B):3779-83. PubMed ID: 9042257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]